THE ACCEPTABILITY OF A COMBINED ESTROGEN-PROGESTOGEN CONTRACEPTIVE VAGINAL RING

被引:26
|
作者
WEISBERG, E
FRASER, IS
MISHELL, DR
LACARRA, M
BARDIN, CW
机构
[1] UNIV SYDNEY, SYDNEY CTR REPROD HLTH RES, DEPT OBSTET & GYNAECOL, SYDNEY, NSW 2006, AUSTRALIA
[2] POPULAT COUNCIL, CTR BIOMED RES, NEW YORK, NY 10021 USA
[3] UNIV SO CALIF, SCH MED, DEPT OBSTET & GYNECOL, LOS ANGELES, CA 90033 USA
关键词
CONTRACEPTION; ESTROGEN; PROGESTOGEN VAGINA; RING; ACCEPTABILITY;
D O I
10.1016/0010-7824(94)00005-H
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
The acceptability of a vaginal ring releasing ethinyl oestradiol 20 meg per day and norethindrone acetate I mg per day was assessed during a six-month phase II trial comparing three different regimens, which was carried out simultaneously in Los Angeles and Sydney. Sixty women were enrolled in Sydney and 90 in Los Angeles. On admission into the study, the women were asked to complete a questionnaire which gave details of age, last contraceptive method used, contraceptive methods used in the past and their reason for liking or disliking previous contraceptive methods, as well as their reason for stopping the last method. On completion of the study or leaving the study for any reason, each woman was asked to complete an acceptability questionnaire which included her experiences with the ring and the rating of the method. The responses to these two questionnaires form the basis of this report. The overall rating of the ring was similar in both the Sydney and Los Angeles groups. Sixty-nine percent of women rated the method as very good. Seventy-two percent of women in Los Angeles and 62% of women in Sydney liked the ring much more than their most liked previous method. In both groups the method they liked best apart from the ring was the pill (62% in Sydney and 53% in Los Angeles), The major reasons for liking the ring were convenience of use, effectiveness and no requirements for taking medication daily. Most women in both studies would recommend the ring to others (92% in Sydney and 89% in Los Angeles).
引用
收藏
页码:39 / 44
页数:6
相关论文
共 50 条
  • [41] Factors associated with nonadherence to instructions for using the Nestorone®/ethinyl estradiol contraceptive vaginal ring
    Stifani, Bianca M.
    Plagianos, Marlena
    Vieira, Carolina Sales
    Merkatz, Ruth B.
    CONTRACEPTION, 2018, 97 (05) : 415 - 421
  • [42] Risk factors for and outcomes of ring expulsions with a 1-year contraceptive vaginal system
    Plagianos, Marlena G.
    Ramanadhan, Shaalini
    Merkatz, Ruth B.
    Brache, Vivian
    Friedland, Barbara A.
    Haddad, Lisa B.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2024, 230 (05)
  • [43] Extended regimens of the contraceptive vaginal ring: evaluation of clinical aspects
    Barreiros, Fernando Augusto
    Falbo Guazzelli, Cristina Aparecida
    Barbosa, Ricardo
    de Assis, Francisco
    de Araujo, Fabio Fernando
    CONTRACEPTION, 2010, 81 (03) : 223 - 225
  • [44] Residual hormone levels in used contraceptive rings as a measurement of adherence to vaginal ring use
    Haaland, Richard E.
    Holder, Angela
    Evans-Strickfaden, Tammy
    Nyagol, Beatrice
    Makanga, Mumbi
    Oyaro, Boaz
    Humwa, Felix
    Williams, Tiffany
    McLellan-Lemal, Eleanor
    Desai, Mitesh
    Huey, Michael J.
    CONTRACEPTION, 2017, 95 (06) : 602 - 604
  • [45] A CONTRACEPTIVE VAGINAL RING RELEASING NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL
    BALLAGH, SA
    MISHELL, DR
    LACARRA, M
    SHOUPE, D
    JACKANICZ, TM
    EGGENA, P
    CONTRACEPTION, 1994, 50 (06) : 517 - 533
  • [46] CONTRACEPTIVE VAGINAL RING AND FEMALE SEXUAL FUNCTION IN KIGALI, RWANDA
    Delvaux, Therese
    Kestelyn, Evelyne
    Van Nuil, J.
    Umulisa, M.
    Uwineza, M.
    Umutoni, G.
    Agaba, S.
    De Baetselier, I.
    Nostlinger, C.
    Jespers, V.
    Crucitti, T.
    Van De Wijgert, J.
    JOURNAL OF SEXUAL MEDICINE, 2017, 14 (05) : E329 - E329
  • [47] Impact on hepatic estrogen-sensitive proteins by a 1-year contraceptive vaginal ring delivering Nestorone® and ethinyl estradiol
    Archer, D. F.
    Thomas, M. A.
    Conard, J.
    Merkatz, R. B.
    Creasy, G. W.
    Roberts, K.
    Plagianos, M.
    Blithe, D.
    Sitruk-Ware, R.
    CONTRACEPTION, 2016, 93 (01) : 58 - 64
  • [48] Comparison of combined hormonal vaginal ring with ultralow-dose combined oral contraceptive pills in the management of heavy menstrual bleeding: A pilot study
    Agarwal, N.
    Gupta, M.
    Kriplani, A.
    Bhatla, N.
    Singh, N.
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2016, 36 (01) : 71 - 75
  • [49] Acceptability and Satisfaction of Contraceptive Vaginal Rings in Clinical Studies: A Systematic Review and Narrative Synthesis
    Delvaux, Therese
    Jespers, Vicky
    Benova, Lenka
    van de Wijgert, Janneke
    FRONTIERS IN GLOBAL WOMENS HEALTH, 2021, 2
  • [50] Progesterone vaginal ring: introducing a contraceptive to meet the needs of breastfeeding women
    RamaRao, Saumya
    Clark, Heather
    Merkatz, Ruth
    Sussman, Heather
    Sitruk-Ware, Regine
    CONTRACEPTION, 2013, 88 (05) : 591 - 598